These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

90 related items for PubMed ID: 12738746

  • 1. Cyclin d1 overexpression sensitizes breast cancer cells to fenretinide.
    Pirkmaier A, Yuen K, Hendley J, O'Connell MJ, Germain D.
    Clin Cancer Res; 2003 May; 9(5):1877-84. PubMed ID: 12738746
    [Abstract] [Full Text] [Related]

  • 2. Cyclin D1 overexpression and response to bortezomib treatment in a breast cancer model.
    Ishii Y, Pirkmaier A, Alvarez JV, Frank DA, Keselman I, Logothetis D, Mandeli J, O'Connell MJ, Waxman S, Germain D.
    J Natl Cancer Inst; 2006 Sep 06; 98(17):1238-47. PubMed ID: 16954476
    [Abstract] [Full Text] [Related]

  • 3. Tamoxifen stimulates the growth of cyclin D1-overexpressing breast cancer cells by promoting the activation of signal transducer and activator of transcription 3.
    Ishii Y, Waxman S, Germain D.
    Cancer Res; 2008 Feb 01; 68(3):852-60. PubMed ID: 18245487
    [Abstract] [Full Text] [Related]

  • 4. Overexpression of cyclin DI contributes to malignant properties of esophageal tumor cells by increasing VEGF production and decreasing Fas expression.
    Shintani M, Okazaki A, Masuda T, Kawada M, Ishizuka M, Doki Y, Weinstein IB, Imoto M.
    Anticancer Res; 2002 Feb 01; 22(2A):639-47. PubMed ID: 12014632
    [Abstract] [Full Text] [Related]

  • 5. Synergistic effect of cyclin D1 and c-Myc leads to more aggressive and invasive mammary tumors in severe combined immunodeficient mice.
    Wang Y, Thakur A, Sun Y, Wu J, Biliran H, Bollig A, Liao DJ.
    Cancer Res; 2007 Apr 15; 67(8):3698-707. PubMed ID: 17440082
    [Abstract] [Full Text] [Related]

  • 6. Prolonged response to antisense cyclin D1 in a human squamous cancer xenograft model.
    Sauter ER, Herlyn M, Liu SC, Litwin S, Ridge JA.
    Clin Cancer Res; 2000 Feb 15; 6(2):654-60. PubMed ID: 10690551
    [Abstract] [Full Text] [Related]

  • 7. Constitutive overexpression of cyclin D1 does not prevent inhibition of hormone-responsive human breast cancer cell growth by antiestrogens.
    Pacilio C, Germano D, Addeo R, Altucci L, Petrizzi VB, Cancemi M, Cicatiello L, Salzano S, Lallemand F, Michalides RJ, Bresciani F, Weisz A.
    Cancer Res; 1998 Mar 01; 58(5):871-6. PubMed ID: 9500441
    [Abstract] [Full Text] [Related]

  • 8. Inhibition of anchorage-independent cell growth, adhesion, and cyclin D1 gene expression by a dominant negative mutant of a tyrosine phosphatase.
    Mitra SK, Swarup G.
    Exp Cell Res; 2001 Oct 15; 270(1):32-44. PubMed ID: 11597125
    [Abstract] [Full Text] [Related]

  • 9. Protein kinase C beta enhances growth and expression of cyclin D1 in human breast cancer cells.
    Li H, Weinstein IB.
    Cancer Res; 2006 Dec 01; 66(23):11399-408. PubMed ID: 17145886
    [Abstract] [Full Text] [Related]

  • 10. Specific protection against breast cancers by cyclin D1 ablation.
    Yu Q, Geng Y, Sicinski P.
    Nature; 2001 Jun 28; 411(6841):1017-21. PubMed ID: 11429595
    [Abstract] [Full Text] [Related]

  • 11. c-Myc-induced chemosensitization is mediated by suppression of cyclin D1 expression and nuclear factor-kappa B activity in pancreatic cancer cells.
    Biliran H, Banerjee S, Thakur A, Sarkar FH, Bollig A, Ahmed F, Wu J, Sun Y, Liao JD.
    Clin Cancer Res; 2007 May 01; 13(9):2811-21. PubMed ID: 17473215
    [Abstract] [Full Text] [Related]

  • 12. Cyclin D1 overexpression enhances radiation-induced apoptosis and radiosensitivity in a breast tumor cell line.
    Coco Martin JM, Balkenende A, Verschoor T, Lallemand F, Michalides R.
    Cancer Res; 1999 Mar 01; 59(5):1134-40. PubMed ID: 10070974
    [Abstract] [Full Text] [Related]

  • 13. Cyclin D1 is necessary but not sufficient for anchorage-independent growth of rat mammary tumor cells and is associated with resistance of the Copenhagen rat to mammary carcinogenesis.
    Li YJ, Song R, Korkola JE, Archer MC, Ben-David Y.
    Oncogene; 2003 May 29; 22(22):3452-62. PubMed ID: 12776197
    [Abstract] [Full Text] [Related]

  • 14. Suppression of Neu-induced mammary tumor growth in cyclin D1 deficient mice is compensated for by cyclin E.
    Bowe DB, Kenney NJ, Adereth Y, Maroulakou IG.
    Oncogene; 2002 Jan 10; 21(2):291-8. PubMed ID: 11803472
    [Abstract] [Full Text] [Related]

  • 15. Requirement for CDK4 kinase function in breast cancer.
    Yu Q, Sicinska E, Geng Y, Ahnström M, Zagozdzon A, Kong Y, Gardner H, Kiyokawa H, Harris LN, Stål O, Sicinski P.
    Cancer Cell; 2006 Jan 10; 9(1):23-32. PubMed ID: 16413469
    [Abstract] [Full Text] [Related]

  • 16. Transduction of antisense cyclin D1 using two-step gene transfer inhibits the growth of rat hepatoma cells.
    Uto H, Ido A, Moriuchi A, Onaga Y, Nagata K, Onaga M, Tahara Y, Hori T, Hirono S, Hayashi K, Tsubouchi H.
    Cancer Res; 2001 Jun 15; 61(12):4779-83. PubMed ID: 11406552
    [Abstract] [Full Text] [Related]

  • 17. Overexpression of the low molecular weight cyclin E in transgenic mice induces metastatic mammary carcinomas through the disruption of the ARF-p53 pathway.
    Akli S, Van Pelt CS, Bui T, Multani AS, Chang S, Johnson D, Tucker S, Keyomarsi K.
    Cancer Res; 2007 Aug 01; 67(15):7212-22. PubMed ID: 17671189
    [Abstract] [Full Text] [Related]

  • 18. Is Cyclin D1-CDK4 kinase a bona fide cancer target?
    Malumbres M, Barbacid M.
    Cancer Cell; 2006 Jan 01; 9(1):2-4. PubMed ID: 16413464
    [Abstract] [Full Text] [Related]

  • 19. Cyclin D1 is essential for neoplastic transformation induced by both E6/E7 and E6/E7/ErbB-2 cooperation in normal cells.
    Al Moustafa AE, Foulkes WD, Wong A, Jallal H, Batist G, Yu Q, Herlyn M, Sicinski P, Alaoui-Jamali MA.
    Oncogene; 2004 Jul 01; 23(30):5252-6. PubMed ID: 15229656
    [Abstract] [Full Text] [Related]

  • 20. Identification of cyclin D1- and estrogen-regulated genes contributing to breast carcinogenesis and progression.
    Yang C, Trent S, Ionescu-Tiba V, Lan L, Shioda T, Sgroi D, Schmidt EV.
    Cancer Res; 2006 Dec 15; 66(24):11649-58. PubMed ID: 17178859
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.